Abstracts tagged "Arthritis and systemic sclerosis"

Abstract Number: 2711 • 2014 ACR/ARHP Annual Meeting
Joint and Tendon Involvement Predict Severe Disease Progression in Systemic Sclerosis: A Prospective Study
Jerome Avouac¹, Ulrich Walker², Eric Hachulla³, Gabriela Riemekasten⁴, Giovanna Cuomo⁵, Patricia E. Carreira⁶, Paola Caramaschi⁷, Lidiya P. Ananieva⁸, Marco Matucci-Cerinic⁹, Laszlo Czirjak¹⁰, Christopher P. Denton¹¹, Ulf Muller-Ladner¹² and Yannick Allanore¹³, ¹Paris Descartes University and INSERM U1016, Rheumatology A department, Cochin Hospital, Paris, France, ²Department of Rheumatology, Basel University, basel, Switzerland, ³Internal Medicine, National Scleroderma Centre, Lille CEDEX, France, ⁴Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, ⁵Department of Internal and Experimental Medicine, Second University of Naples, Naples, Italy, ⁶Rheumatology Department. Hospital Universitario 12 de Octubre, Madrid, Spain, ⁷Rheumatology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy, ⁸Microcirculation and Inflammation, Research Institute of Rheumatology RAMS, Moscow, Russia, ⁹Dept of Medicine/Div of Rheum, University of Florence, Florence, Italy, ¹⁰Rheumatology and Immunology Medical School, University of Pécs, Pécs, Hungary, ¹¹Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom, ¹²Internal Medicine/Rheumatology, Univ Giessen/Kerckhoff-Clinic, Bad Nauheim, Germany, ¹³Paris Descartes University, Rheumatology A Department and INSERM U1016, Cochin Hospital, Paris, France
Background/Purpose Joint involvement is frequent and strongly contributes to impaired quality of life in systemic sclerosis (SSc). In a previous cross-sectional study, synovitis and tendon…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].